KERECIS
Kerecis develops patented fish-skin products to heal the human body. Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal substitute for human skin. More than 50 studies have been done on Kerecis technology. Those studies include two double-blind, comparative, randomized control trials, where fish skin treatment was more efficacious than mammalian-based treatments. ... Kerecis is also developing products for areas such as oral surgery, plastic surgery, and neurological applications. The company's products utilize multiple patented fatty-acid technologies to protect and regenerate tissue across two core technologies such as Kerecis Omega3 Fish Skin and Kerecis Omega3 Viruxide.
KERECIS
Industry:
Health Care Manufacturing Medical Medical Device
Founded:
2009-01-01
Address:
Ísafjörður, Vestur-Isafjardarsysla, Iceland
Country:
Iceland
Website Url:
http://www.kerecis.com
Total Employee:
101+
Status:
Active
Contact:
703-287-8752
Total Funding:
127.61 M USD
Technology used in webpage:
IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Wordpress Plugins Nginx Sitelinks Search Box Euro Amazon Microsoft Azure DNS
Similar Organizations
Litilit
Well-designed, reliable and affordable femtosecond lasers
Affluent Medical
Affluent Medical is develops innovative new-generation mini-invasive implants to restore essential physiological functions.
Amber Implants
Improving the quality of life of the global aging population
Berlin Heart GmbH
Berlin Heart GmbH is a company that develops, produces and markets innovative devices for mechanically supporting the heart.
BrainQ
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach.
Circadiance
Circadiance develops, manufactures, and markets respiratory products for people with sleep-disordered breathing
Cirdan
Cirdan delivers solutions that enable rapid implementation of a robust and scalable digital pathology workflow into a laboratory.
Common Sensing
Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
ConvaTec
ConvaTec specializes in the development, manufacture, distribution of single-use devices to hospitals and healthcare sectors.
Dianax
Dianax develops and manufactures labs-on-chip aiming to transform protein-based diagnostics.
Finesse Medical
Finesse Medical specialises in the development, Manufacture and Marketing of a range of advanced technologies.
Healthium Medtech
Healthium MedTech manufactures and sells a broad range of medical devices and consumable products.
Mecuris
Mecuris develops tailor-made prostheses and orthoses from the 3D printer.
MedTrade Products Ltd
MedTrade Products Limited develops and manufactures woundcare and consumer healthcare products for brands owners.
Meinkind
Meinkind manufactures baby toys, baby car seat, baby care and bath products.
Metix
Metix develops devices and services for healthcare industry.
Mimetis Biomaterials
Mimetis Biomaterials designs, manufactures and commercializes biomimetic bone regenerative solutions in the dental and orthopaedic fields.
Novagenit Srl
Novagenit Srl researches, develops, manufactures and markets within orthopaedics bioabsorbable implantable medical devices and technology.
Oxehealth
SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
RTsafe
RTsafe developed, patented and commercialized the worlds first Personalized Care service (FDA cleared) in Radiation Oncology.
Vivani Medical
Vivani Medical manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence.
Sidekick Health
Sidekick is a patient-centric digital care platform that is scalable across a wide range of chronic illnesses.
Simplify Medical
Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine.
SpinDiag
Spindiag develops an easy-to-use, compact, and automated point-of-care system.
ThermiAesthetics
ThermiAesthetics is a developer and manufacturer of thermistor-regulated energy systems for plastic surgery and dermatology applications.
Xinrong
Xinrong is specialized in manufacturing plastic pipe extrusion, profile extrusion, sheet extrusion and plastic recycling lines.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
2013-06-01
Board_member
Board_member
Advisor
2017-10-01
Current Employees Featured
Gudmundur Fertram Sigurjonsson Founder, President & CEO @ Kerecis
Founder, President & CEO
2009-01-01
Dora Gisladottir VP Product Development and Registration @ Kerecis
VP Product Development and Registration
2017-11-01
Christopher Harte Chief Operating Officer & Channel Manager @ Kerecis
Chief Operating Officer & Channel Manager
2015-03-01
Gudmundur Magnus Hermannsson VP Finance & Operations @ Kerecis
VP Finance & Operations
2015-01-01
Hilmar Kjartansson (MD) VP Clinical Development @ Kerecis
VP Clinical Development
2018-01-01
J. Ernest Kenney Co-Founder & Patent Counsel @ Kerecis
Co-Founder & Patent Counsel
Baldur Tumi Baldursson (MD) Co-Founder & Medical Director @ Kerecis
Co-Founder & Medical Director
Brian Lynn Thomas Director of Manufacturing @ Kerecis
Director of Manufacturing
Mark Marghie Director of Strategic Development and Legal Affairs @ Kerecis
Director of Strategic Development and Legal Affairs
2016-06-01
Baldvin Haraldsson Corporate Counsel @ Kerecis
Corporate Counsel
Founder
Investors List
Brú Pension Fund
Brú Pension Fund investment in Series D - Kerecis
Emerson Collective
Emerson Collective investment in Series D - Kerecis
LSV
LSV investment in Series D - Kerecis
KIRKBI A/S
KIRKBI A/S investment in Series D - Kerecis
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Kerecis
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Kerecis
Alvogen
Alvogen investment in Series C - Kerecis
CuraeLab
CuraeLab investment in Series C - Kerecis
Emerson Collective
Emerson Collective investment in Series C - Kerecis
Novator
Novator investment in Series C - Kerecis
Official Site Inspections
http://www.kerecis.com Semrush global rank: 2.63 M Semrush visits lastest month: 6.52 K
- Host name: kerecis.tempurl.host
- IP address: 45.77.139.231
- Location: Amsterdam Netherlands
- Latitude: 52.3891
- Longitude: 4.6563
- Timezone: Europe/Amsterdam
- Postal: 2031
Kerecis.com lookup results from whois.networksolutions.com server:
- Domain created: 21st-Jul-2007
- Domain updated: 27th-Dec-2023
- Domain expires: 21st-Jul-2028 3 Years, 88 Days left
- Website age: 17 Years, 277 Days
- Registrar Domain ID: 1099938701_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS1-32.AZURE-DNS.COM
- NS2-32.AZURE-DNS.NET
- NS3-32.AZURE-DNS.ORG
- NS4-32.AZURE-DNS.INFO
More informations about "Kerecis"
Intact Fish Skin for Tissue Regeneration - Kerecis.com
Dec 27, 2024 The intact Kerecis fish skin is being used to treat wounds, burns and other complex acute and chronic wounds including diabetic, venous, trauma, and surgical wounds. …See details»
Kerecis - Crunchbase Company Profile & Funding
Kerecis develops patented fish-skin products to heal the human body. Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, …See details»
Kerecis - Wikipedia
Kerecis is an Icelandic company that uses fish skins to treat wounds. The decellularized skin of the Atlantic cod is used as a graft, which increases the elasticity, tensile strength, and compressibility of the wound. Kerecis has subsidiaries in Switzerland and the United States. It is based in Ísafjörður, Iceland. See details»
Overview - Kerecis
We provide our customers with tools for managing their business with Kerecis real time. The Kerecis Current application and artificial intelligence (AI) allows for secure submission and monitoring of insurance verification and billing support …See details»
Kerecis Company Profile 2024: Valuation, Investors, …
When was Kerecis founded? Kerecis was founded in 2007. Where is Kerecis headquartered? Kerecis is headquartered in Isafjordur, Iceland. What is the size of Kerecis? Kerecis has 550 total employees. What industry is Kerecis in? …See details»
Coloplast completes the acquisition of Kerecis
Says Fertram Sigurjonsson, founder and CEO of Kerecis, who will continue to lead the Kerecis team. As a result of the agreement to acquire Kerecis, Coloplast raised its long-term organic …See details»
Kerecis - Contacts, Employees, Board Members, Advisors & Alumni
Kerecis has 11 current employee profiles, including Founder, President & CEO Gudmundur Fertram Sigurjonsson. Kerecis has 13 board members and advisors, including Gudmundur …See details»
Kerecis - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Kerecis - Org Chart, Teams, Culture & Jobs - The Org
View Kerecis' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Kerecis Company Profile - Office Locations, Competitors ... - Craft
Kerecis develops, manufactures and markets patented Omega3 rich fish skin. Its products are currently being used to regenerate tissue in trauma and chronic wounds such as burns and …See details»
A Brief History of Kerecis – CANVAS, SWOT, PESTEL & BCG Matrix …
Oct 2, 2024 A Brief History of Kerecis traces back to the early 21st century in Iceland, where a team of innovative scientists and biotechnology experts came together with a shared vision to …See details»
Kerecis - Products, Competitors, Financials, Employees, …
Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy. Nov 14, 2024. Coloplast A/S On 14 November 2024, the U.S. Centers for Medicare & …See details»
Kerecis AG - Swiss Biotech
Kerecis is a life science company that develops or acquires intellectual property from natural product extracts, defines scientifically sound development protocols, manages product …See details»
Our Mission - Kerecis
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy. Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.See details»
Mission, Vision & Core Values of Kerecis – CANVAS, SWOT, PESTEL …
Oct 2, 2024 One of the key missions of Kerecis is to provide innovative and effective solutions for chronic wounds that are difficult to heal using traditional methods. By harnessing the power …See details»
Kerecis Current
Kerecis Current uses state-of-the-art technology to provide real-time access to benefit investigations, your order information and Kerecis literature. Username * Password * Log In. …See details»
Coloplast A/S (CLPBF) Q1 2023/2024 Earnings Call Transcript
Feb 9, 2024 Kerecis is still expected to contribute around four percentage points to the reported revenue growth. We continue to expect a reported EBIT margin before special items of 27% to …See details»
Sustainability - Kerecis
We at Kerecis create tremendous value from a small amount of waste, and the benefits are far-reaching and often immeasurable. ... and Festa, Iceland’s leading corporate social …See details»
Kerecis Workspace
Employee Login. External LoginSee details»
Careers - Kerecis
Kerecis has in the last two years transitioned from being a research and development company into commercialization and is experiencing rapid growth and outstanding patient results. …See details»